Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
295.95
-0.46 (-0.16%)
May 16, 2025, 9:45 AM - Market open
Medpace Holdings Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Medpace Holdings stock ranges from a low of $300 to a high of $432. The average analyst price target of $343.22 forecasts a 15.97% increase in the stock price over the next year.
Price Target: $343.22 (+15.97%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medpace Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 6 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $333 → $300 | Hold | Maintains | $333 → $300 | +1.37% | Apr 23, 2025 |
Baird | Baird | Hold Maintains $340 → $313 | Hold | Maintains | $340 → $313 | +5.76% | Apr 23, 2025 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 22, 2025 |
TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $370 → $328 | Strong Buy → Hold | Downgrades | $370 → $328 | +10.83% | Apr 14, 2025 |
Truist Securities | Truist Securities | Hold Maintains $347 → $333 | Hold | Maintains | $347 → $333 | +12.52% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
2.23B
from 2.11B
Increased by 5.59%
Revenue Next Year
2.30B
from 2.23B
Increased by 3.46%
EPS This Year
12.51
from 12.63
Decreased by -0.92%
EPS Next Year
13.79
from 12.51
Increased by 10.16%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.3B | 2.5B | 2.8B | ||
Avg | 2.2B | 2.3B | 2.5B | ||
Low | 2.1B | 2.1B | 2.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.4% | 13.4% | 23.3% | ||
Avg | 5.6% | 3.5% | 8.9% | ||
Low | -0.6% | -3.6% | -1.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.24 | 15.03 | 17.81 | ||
Avg | 12.51 | 13.79 | 15.59 | ||
Low | 11.76 | 12.50 | 13.62 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.8% | 20.1% | 29.2% | ||
Avg | -0.9% | 10.2% | 13.1% | ||
Low | -6.9% | -0.1% | -1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.